USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
IsoTherapeutics Group LLC
Address:
1004 S. Velasco
Angleton, TX 77515-5250
Phone:
N/A
URL:
N/A
EIN:
203863390
DUNS:
621139976
Number of Employees:
14
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $442,858.00 3
SBIR Phase II $989,748.00 1

Award List:

A new radiopharmaceutical for the treatment of metastatic bone cancer

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$143,582.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Bone-seeking radiopharmaceuticals are used extensively for bone pain palliation and have shown promise for treating bone metastases. They typically combine a radioactive metal such as samarium-153 with a chelator. The chelator part of the molecule is taken up… More

High Specific Activity Sm-153 by Post Irradiation Isotope Separation

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$149,476.00
Agency:
DOE
Principal Investigator:
Jaime Simon, Dr. – 979-848-0800
Abstract:
When the stable samarium-152 (Sm-152) isotope is irradiated, radioactive samarium-153 (Sm-153) is produced through a neutron capture reaction in yields of only about 2%, and this radioactive, therapeutic isotope (Sm-153) cannot be separated from the much more abundant (~98%) non-radioactive isotope… More

High Specific Activity Sm-153 by Post Irradiation Isotope Separation

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$989,748.00
Agency:
DOE
Principal Investigator:
Jaime Simon, Dr. – 979-848-0800
Abstract:
Samarium-153 (153Sm) has ideal nuclear properties for a variety of therapeutic applications; however, it is only available in low specific activity (radioactivity/weight) form. While large quantities can be made by the 152Sm(n,)153Sm reaction in a medium flux reactor such as at the University… More

High Specific Activity Sn-117m by Post Irradiation Isotope Separation

Award Year / Program / Phase:
2014 / SBIR / Phase I
Award Amount:
$149,800.00
Agency:
DOE
Principal Investigator:
Abstract:
The radioisotope tin-117m (117mSn) is a theranostic isotope that is suitable for both diagnostic and therapeutic applications. Its low energy gamma rays can be imaged using standard gamma cameras. For therapy its short-range ( & lt;300 micron) conversion electrons minimize damage to healthy… More